等待开盘 02-05 09:30:00 美东时间
+3.005
+3.58%
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
Gainers X3 Holdings (NASDAQ:XTKG) stock increased by 124.7% to $0.6 during Tue...
01-27 20:05
Needham analyst Mayank Tandon reiterates Agilysys (NASDAQ:AGYS) with a Buy and maintains $140 price target.
01-27 19:10
Agilysys (AGYS) shares fell 12% in premarket trading on Tuesday after the hospitality software firm missed profit expectations, while management pointed to uneven deal timing behind softer internation...
01-27 18:48
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Agilysys业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q3总营收达到创纪录的6960万美元,同比增长14.9%,连续第12个季度创收入新高 - 产品营收1070万美元,同比下降15.8%,主要受永久许可证和POS相关硬件销售下滑影响 - 经常性营收4440万美元,创历史新高,同比增长26.4%,占总营收的63.8% - 订阅营收2830万美元,同比增长45.1%,环比增长330万美元,占经常性营收的63.8% - 服务营收1450万美元,同比增长13.5% **盈利能力:** - 毛利润4390万美元
01-27 12:03
Earnings Call Insights: Agilysys, Inc. (AGYS) Q3 2026 Management View CEO Ramesh Srinivasan reported "Q3 fiscal 2026 was the second best Q3 October to December period sales quarter" and described it a...
01-27 08:43
华盛资讯1月27日讯,阿吉赛斯公布2025财年Q4业绩,公司Q4营收0.80亿美元,同比增长15.6%,归母净利润0.10亿美元,同比增长158.4%。
01-27 05:50
Here's a look inside the Q3 earnings report from Agilysys.
01-27 05:30
Agilysys shares are trading lower after the company reported mixed Q3 financial...
01-27 05:21